Gadd45α: A Novel Diabetes-Associated Gene Potentially Linking Diabetic Cardiomyopathy and Baroreflex Dysfunction

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Wang, Ning ^a,b   Yang, Chao ^a   Xie, Fang ^a   Sun, Lihua ^a,b   Su, Xiaolin ^a   Wang, Ying ^a   Wei, Ran ^a   Zhang, Rong ^a,b   Li, Xia ^a   Yang, Baofeng ^a,b   Ai, Jing ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 ALPHA; MICRORNA; MICRORNA 499; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; GADD45ALPHA GENE; GENE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART; HEART LEFT VENTRICLE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESSORECEPTOR REFLEX; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; REFERENCE DATABASE; REFLEX DISORDER; SPINAL GANGLION; STREPTOZOCIN DIABETES; TISSUE LEVEL;

ANIMALS; BAROREFLEX; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELLS, CULTURED; DIABETIC CARDIOMYOPATHIES; HUMANS; MALE; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR;

RATTUS;

EID: 84870789610     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049077     Document Type: Article

References (47)

1. King H, Aubert RE, Herman WH, (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-1431.
2. Balkau B, Jouven X, Ducimetiere P, Eschwege E, (1999) Diabetes as a risk factor for sudden death. Lancet 354: 1968-1969.
3. Francis GS, (2001) Diabetic cardiomyopathy: fact or fiction? Heart 85: 247-248.
4. Lawrence IG, Weston PJ, Bennett MA, McNally PG, Burden AC, et al. (1997) Is impaired baroreflex sensitivity a predictor or cause of sudden death in insulin-dependent diabetes mellitus? Diabet Med 14: 82-85.
5. Poirier P, Bogaty P, Philippon F, Garneau C, Fortin C, et al. (2003) Preclinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes. Metabolism 52: 1056-1061.
6. Fang ZY, Prins JB, Marwick TH, (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25: 543-567.
7. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
8. Kantharidis P, Wang B, Carew RM, Lan HY, (2011) Diabetes complications: the microRNA perspective. Diabetes 60: 1832-1837.
9. Katare R, Caporali A, Zentilin L, Avolio E, Sala-Newby G, et al. (2011) Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ Res 108: 1238-1251.
10. Feng B, Chen S, George B, Feng Q, Chakrabarti S, (2010) miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev 26: 40-49.
11. Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, et al. (2009) MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 36: 181-188.
12. Glyn-Jones S, Song S, Black MA, Phillips AR, Choong SY, et al. (2007) Transcriptomic analysis of the cardiac left ventricle in a rodent model of diabetic cardiomyopathy: molecular snapshot of a severe myocardial disease. Physiol Genomics 28: 284-293.
13. Price SA, Zeef LA, Wardleworth L, Hayes A, Tomlinson DR, (2006) Identification of changes in gene expression in dorsal root ganglia in diabetic neuropathy: correlation with functional deficits. J Neuropathol Exp Neurol 65: 722-732.
14. Yan B, Li L, Harden SW, Gozal D, Lin Y, et al. (2009) Chronic intermittent hypoxia impairs heart rate responses to AMPA and NMDA and induces loss of glutamate receptor neurons in nucleus ambiguous of F344 rats. Am J Physiol Regul Integr Comp Physiol 296: R299-308.
15. Lee JG, Kang DG, Yu JR, Kim Y, Kim J, et al. (2011) Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity. Diabetes Metab J 35: 149-158.
16. Ghaemi Oskouie F, Shameli A, Yang A, Desrosiers MD, Mucsi AD, et al. (2011) High levels of adenosine deaminase on dendritic cells promote autoreactive T cell activation and diabetes in nonobese diabetic mice. J Immunol 186: 6798-6806.
17. Hamada Y, Fukagawa M, (2007) A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy. Kobe J Med Sci 53: 53-61.
18. Rosemary Siafakas A, Richardson DR, (2009) Growth arrest and DNA damage-45 alpha (GADD45alpha). Int J Biochem Cell Biol 41: 986-989.
19. Yan B, Li L, Harden SW, Epstein PN, Wurster RD, et al. (2009) Diabetes induces neural degeneration in nucleus ambiguus (NA) and attenuates heart rate control in OVE26 mice. Exp Neurol 220: 34-43.
20. Guttula SV, Rao AA, Sridhar GR, Chakravarthy MS, Nageshwararo K, et al. (2010) Cluster analysis and phylogenetic relationship in biomarker identification of type 2 diabetes and nephropathy. Int J Diabetes Dev Ctries 30: 52-56.
21. Garcia-Villegas R, Lopez-Alvarez LE, Arni S, Rosenbaum T, Morales MA, (2009) Identification and functional characterization of the promoter of the mouse sodium-activated sodium channel Na(x) gene (Scn7a). J Neurosci Res 87: 2509-2519.
22. Lal A, Gorospe M, (2006) Egad, more forms of gene regulation: the gadd45a story. Cell Cycle 5: 1422-1425.
23. Moskalev AA, Smit-McBride Z, Shaposhnikov MV, Plyusnina EN, Zhavoronkov A, et al. (2011) Gadd45 proteins: Relevance to aging, longevity and age-related pathologies. Ageing Res Rev 11: 51-66.
24. Jenuwein T, Allis CD, (2001) Translating the histone code. Science 293: 1074-1080.
25. Gray SG, De Meyts P, (2005) Role of histone and transcription factor acetylation in diabetes pathogenesis. Diabetes Metab Res Rev 21: 416-433.
26. Christensen DP, Dahllof M, Lundh M, Rasmussen DN, Nielsen MD, et al. (2011) Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus. Mol Med 17: 378-390.
27. Lefebvre P, Chinetti G, Fruchart JC, Staels B, (2006) Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 116: 571-580.
28. Doney AS, Fischer B, Lee SP, Morris AD, Leese G, et al. (2005) Association of common variation in the PPARA gene with incident myocardial infarction in individuals with type 2 diabetes: a Go-DARTS study. Nucl Recept 3: 4.
29. Cresci S, Huss JM, Beitelshees AL, Jones PG, Minton MR, et al. (2010) A PPARalpha promoter variant impairs ERR-dependent transactivation and decreases mortality after acute coronary ischemia in patients with diabetes. PLoS One 5: e12584.
30. Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, et al. (2000) Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci U S A 97: 4291-4296.
31. Monkemann H, De Vriese AS, Blom HJ, Kluijtmans LA, Heil SG, et al. (2002) Early molecular events in the development of the diabetic cardiomyopathy. Amino Acids 23: 331-336.
32. Al-Douahji M, Brugarolas J, Brown PA, Stehman-Breen CO, Alpers CE, et al. (1999) The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy. Kidney Int 56: 1691-1699.
33. Kaneto H, Kajimoto Y, Fujitani Y, Matsuoka T, Sakamoto K, et al. (1999) Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction. Diabetologia 42: 1093-1097.
34. Brizzi MF, Dentelli P, Pavan M, Rosso A, Gambino R, et al. (2002) Diabetic LDL inhibits cell-cycle progression via STAT5B and p21(waf). J Clin Invest 109: 111-119.
35. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, et al. (2010) Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3: 499-506.
36. Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, et al. (2010) Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 56: 1183-1185.
37. Shieh JT, Huang Y, Gilmore J, Srivastava D, (2011) Elevated miR-499 levels blunt the cardiac stress response. PLoS One 6: e19481.
38. Fu JD, Rushing SN, Lieu DK, Chan CW, Kong CW, et al. (2011) Distinct Roles of MicroRNA-1 and-499 in Ventricular Specification and Functional Maturation of Human Embryonic Stem Cell-Derived Cardiomyocytes. PLoS One 6: e27417.
39. Wilson KD, Hu S, Venkatasubrahmanyam S, Fu JD, Sun N, et al. (2010) Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ Cardiovasc Genet 3: 426-435.
40. Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, et al. (2010) MicroRNA-1 and-499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol 30: 859-868.
41. Fichtlscherer S, Zeiher AM, Dimmeler S, (2011) Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 31: 2383-2390.
42. Dimmeler S, Zeiher AM, (2010) Circulating microRNAs: novel biomarkers for cardiovascular diseases? Eur Heart J 31: 2705-2707.
43. Kovacs B, Lumayag S, Cowan C, Xu S, (2011) MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 52: 4402-4409.
44. Salama M, Tsuji M, Tamura M, Kagawa S, (1998) Impact of aging and diabetes mellitus on the expression of the proliferating cell nuclear antigen in rat testicular tissue. Arch Androl 40: 95-107.
45. Dhar MS, Yuan JS, Elliott SB, Sommardahl C, (2006) A type IV P-type ATPase affects insulin-mediated glucose uptake in adipose tissue and skeletal muscle in mice. J Nutr Biochem 17: 811-820.
46. Shi H, Lu Y, Du J, Du W, Ye X, et al. (2012) Application of Back Propagation Artificial Neural Network on Genetic Variants in Adiponectin ADIPOQ, Peroxisome Proliferator-Activated Receptor-gamma, and Retinoid X Receptor-alpha Genes and Type 2 Diabetes Risk in a Chinese Han Population. Diabetes Technol Ther 14: 293-300.
47. Kurabe N, Arai S, Nishijima A, Kubota N, Suizu F, et al. (2009) The death effector domain-containing DEDD supports S6K1 activity via preventing Cdk1-dependent inhibitory phosphorylation. J Biol Chem 284: 5050-5055.